Fiducial markers are objects placed in a strategic way to visualize it in an imaging system’s visual representation. These markers are metal objects placed close to a tumor for preparing the patient during a radiation therapy helping physicians use it as a reference point. This helps in isolation of the cancerous cell and focusing the dosage of therapy on that particular area helping to reduce the damage caused towards the surrounding tissue.
Access Full Report at https://www.databridgemarketresearch.com/reports/global-fiducial-markers-market
The main factors behind the growth of the market are:
The market is segmented on the basis of type as polymer-based markers, metal-based markers, others; modality as CT/CBCT, cyberknife, linac, magnetic resonance imaging, proton therapy, tomotherapy; disease site as head & neck, breast, lung, abdomen, prostate, kidney, cervix, other; application as hospitals, radiotherapy, cancer research institutes, others.
Some of the key market developments are as follows:
“According to Data Bridge Market Research, global fiducial markers market is expected to be growing at a substantial CAGR during the forecast period of 2019 to 2026”
Some of the major players operating in the market are Eckert & Ziegler, Boston Scientific Corporation, IBA, Best Medical International, Inc., IZI Medical Products, Carbon Medical Technologies, CIVCO Radiotherapy, Stellar Medical, goldanchormarker.com, Koninklijke Philips N.V., Veran Medical Technologies, MRIequip.com, Medtronic, Hologic, Inc, JJ-MEDTECH among others.
One of the major opportunities available with the market players of fiducial markers is the benefits associated with the usage of fiducial markers in diagnostic procedures for cancer. Their usage even helps in better treatment of cancer as it can help physicians isolate the areas to focus on during the different procedural systems.
Global Fiducial Markers Market – Industry Trends and Forecast to 2028